Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G61418DU
Summary
- GlyTouCan ID
-
G61418DU
- IUPAC Condensed
- GalNAc(b1-
Organisms
| Organisms | Evidence |
|---|---|
| Escherichia coli | |
| Rattus | |
| Cricetulus griseus (Chinese hamster) |
Taxonomic Hierarchy
GlycoGene Database (GGDB)
G01534TU
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
|---|---|---|---|---|
| B4GALT3 | UDP-Gal |
G61418DU
|
4-Me-lumbelyl-[beta] | |
| B4GALT2 | UDP-Gal |
G61418DU
|
4-Me-lumbelyl-[beta] | |
| B4GALT3 | UDP-Gal |
G61418DU
|
o-Nitrophenyl-[beta] | |
| B4GALT7 | UDP-Gal |
G61418DU
|
4-D-MethylUmb-[beta] | |
| B4GALT4 | UDP-Gal |
G61418DU
|
[beta]-1-o-Nitrophenyl |
Pathway
| Pathway Name | Organism |
|---|---|
| E.coli O102 | Escherichia coli |
| E.coli O104 | Escherichia coli |
| E.coli O107 | Escherichia coli |
| E.coli O11 | Escherichia coli |
| E.coli O112ab | Escherichia coli |
| E.coli O112ac | Escherichia coli |
| E.coli O117 | Escherichia coli |
| E.coli O120 | Escherichia coli |
| E.coli O124 | Escherichia coli |
| E.coli O125ab | Escherichia coli |
Sequence Descriptors
- GlycoCT
-
RES 1b:b-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
- WURCS
- WURCS=2.0/1,1,0/[a2112h-1b_1-5_2*NCC/3=O]/1/
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 38204163 | Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases | Li Q | 2024 Mar 06 |
|
| 38860868 | Incorporation of Intracellular NanoSIMS Tracers to Oligonucleotide Conjugates via Strain Promoted Sydnone–Alkyne Cycloaddition | Lincy-Bianchi L | 2024 Jun 11 |
|
| 38044204 | A randomized, placebo-controlled study of givosiran in patients with acute hepatic porphyrias (ENVISION): Final (36-month) analysis of the Taiwan Cohort | Lee M | 2024 Jun |
|
| 39083119 | Phleum pratense-pollen adaptive variations and pollen microbiome investigation under different climatic regions and prospects of allergenicity | Muhammad H | 2024 Jul 31 |
|
| 38993155 | A GalNAc-modified CaCO3 nano-immunomodulator for targeted and responsive immunotherapy against orthotopic liver cancer | Li Y | 2024 Jul 30 |
|
| 39001997 | Lysinibacillus pinottii sp. nov., a novel species with anti-mosquito and anti-mollusk activity | Dunlap CA | 2024 Jul 13 |
|
| 38795858 | Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes | Kundu S | 2024 Jul |
|
| 38172637 | Host genetic regulation of human gut microbial structural variation | Zhernakova DV | 2024 Jan 03 |
|
| 38409587 | RNA interference in the era of nucleic acid therapeutics | Jadhav V | 2024 Feb 26 |
|
| 38535445 | Cloning and Characterization of a Novel N-Acetyl-D-galactosamine-4-O-sulfate Sulfatase, SulA1, from a Marine Arthrobacter Strain | Christensen MD | 2024 Feb 23 |
|
